SG Americas Securities, LLC - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 192 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$502
+0.8%
42,944
+43.1%
0.01%0.0%
Q1 2023$498
+67.1%
30,014
+87.4%
0.01%
+50.0%
Q4 2022$298
-99.9%
16,012
-34.9%
0.00%0.0%
Q3 2022$316,000
-50.2%
24,604
-72.8%
0.00%
-42.9%
Q2 2022$634,000
-25.2%
90,456
-11.5%
0.01%
+16.7%
Q1 2022$848,000
-40.7%
102,235
-51.6%
0.01%
-25.0%
Q4 2021$1,431,000
+199.4%
211,442
+134.2%
0.01%
+300.0%
Q3 2021$478,000
+1305.9%
90,273
+784.8%
0.00%
Q4 2020$34,000
-89.7%
10,203
-90.8%
0.00%
-100.0%
Q3 2020$330,000
+323.1%
111,142
+451.6%
0.00%
+100.0%
Q1 2020$78,000
-48.3%
20,148
-49.9%
0.00%0.0%
Q4 2019$151,000
+287.2%
40,236
+219.9%
0.00%
Q2 2018$39,000
-7.1%
12,576
-27.7%
0.00%
Q1 2018$42,000
-70.8%
17,385
-69.5%
0.00%
-100.0%
Q3 2017$144,000
+128.6%
57,050
+5.4%
0.00%
Q1 2016$63,000
-25.9%
54,123
+90.6%
0.00%
-100.0%
Q3 2015$85,00028,4000.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 148,281$2,4587.14%
GABLES CAPITAL MANAGEMENT INC. 409,080$6,782,5464.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 10,355,099$171,687,5413.83%
JW Asset Management, LLC 563,392$9,341,0393.58%
Quantedge Capital Pte Ltd 324,700$5,383,5262.10%
Paradiem, LLC 236,628$3,923,2921.22%
SummerHaven Investment Management, LLC 100,592$1,667,8150.97%
Capital Impact Advisors, LLC 46,096$764,2720.94%
Yorktown Management & Research Co Inc 50,000$829,0000.89%
Seaport Global Advisors, LLC 15,598$258,6150.82%
View complete list of CATALYST PHARMACEUTICALS INC shareholders